Literature DB >> 10882061

Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones.

B Bergman1, J L McManaman, K Haskins.   

Abstract

The two NOD-derived T cell clones, BDC-2.5 and BDC-6.9, are CD4+, Vbeta4+, islet-specific, and diabetogenic. These two T cell clones show different response patterns to whole islet cell antigen, but were found to respond to the same fraction isolated from beta granule membranes. The clones were used to follow the antigenic activity in the biochemical purification of a beta cell membrane detergent lysate subjected to HPLC anion exchange (IEX) and size exclusion chromatography (SEC). Antigenic activity could be retained after lysis in only one detergent (octyl-beta-glucoside) among several tested. In order to detect solubilized antigen, beta membrane proteins were covalently linked to microlatex beads prior to being added to T cell proliferation assays, a technique that eliminated detergent toxicity and resulted in increased assay sensitivity. To purify the antigen, membrane proteins were absorbed onto an anion exchange column and after elution using a salt gradient, activity for the clones was found in a fraction containing 0.15-0.2 M NaCl. Subsequent analysis of this material by size exclusion chromatography provided an apparent molecular weight of the antigen to be between 50 and 80 kDa. Further attempts to purify the protein by SDS-PAGE resulted in loss of antigenic activity. It is possible that the elusive nature of this protein is a clue to its importance as an autoantigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882061     DOI: 10.1006/jaut.2000.0377

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

Review 1.  Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes.

Authors:  Thomas Delong; Rocky L Baker; Jing He; Kathryn Haskins
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

2.  An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.

Authors:  Timothy A Wiles; Thomas Delong; Rocky L Baker; Brenda Bradley; Gene Barbour; Roger L Powell; Nichole Reisdorph; Kathryn Haskins
Journal:  J Autoimmun       Date:  2016-10-29       Impact factor: 7.094

3.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

4.  Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.

Authors:  Rocky L Baker; Thomas Delong; Gene Barbour; Brenda Bradley; Maki Nakayama; Kathryn Haskins
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

5.  Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.

Authors:  Thomas Delong; Rocky L Baker; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Gene Barbour; Brenda Bradley; Kathryn Haskins
Journal:  Diabetes       Date:  2011-07-06       Impact factor: 9.461

6.  Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.

Authors:  Yang D Dai; Idania G Marrero; Philippe Gros; Habib Zaghouani; Linda S Wicker; Eli E Sercarz
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.